Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Progress and Priorities: Prostate Cancer
Kevin H. Kensler, Timothy R. Rebbeck
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 2, pp. 267-277
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Prostate cancer grading framework based on deep transfer learning and Aquila optimizer
Hossam Magdy Balaha, Ahmed Osama Shaban, Eman M. El-Gendy, et al.
Neural Computing and Applications (2024) Vol. 36, Iss. 14, pp. 7877-7902
Open Access | Times Cited: 14
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Tao Xie, Du-Jiang Fu, Zhimin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
Michelle S. Kim, Daphne Naidoo, Ujani Hazra, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
Xujun You, Junfeng Qiu, Qixin Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Heavy metals and prostate cancer: a new study with new findings
Donatella Coradduzza, Antonella Congiargiu, Andrea Sanna, et al.
Research Square (Research Square) (2025)
Open Access
Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study
Mary K. Downer, Stacey A. Kenfield, Meir J. Stampfer, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 17, pp. 1499-1511
Open Access | Times Cited: 39
The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
Teow J. Phua
Medicines (2021) Vol. 8, Iss. 6, pp. 30-30
Open Access | Times Cited: 25
Prostate cancer epidemiology and prognostic factors in the United States
Saimaitikari Abudoubari, Ke Bu, Yujie Mei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
Sana Raoof, Richard J. Lee, Kunal Jajoo, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 31, Iss. 6, pp. 1139-1145
Open Access | Times Cited: 15
The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features
Michał Olczak, Magdalena Orzechowska, Andrzej K. Bednarek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8399-8399
Open Access | Times Cited: 8
Prostate cancer screening in African American men: a review of the evidence
Kevin H. Kensler, Roman Johnson, Faith Morley, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 1, pp. 34-52
Open Access | Times Cited: 8
Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa
Rohini Janivara, Wenlong Carl Chen, Ujani Hazra, et al.
Nature Genetics (2024) Vol. 56, Iss. 10, pp. 2093-2103
Closed Access | Times Cited: 2
Association between Outdoor Light at Night and Prostate Cancer in the Health Professionals Follow-up Study
Ilkania M. Chowdhury-Paulino, Jaime E. Hart, Peter James, et al.
Cancer Epidemiology Biomarkers & Prevention (2023) Vol. 32, Iss. 10, pp. 1444-1450
Open Access | Times Cited: 6
Salidroside suppresses proliferation and migration in prostate cancer via the PI3K/AKT pathway
Ru-Han Liu, Teng-Fei Ma, Qin Yang, et al.
Cancer Biomarkers (2023) Vol. 38, Iss. 3, pp. 321-332
Closed Access | Times Cited: 6
Pan-African analysis identifies genetic differences in prostate cancer risk

Nature Genetics (2024)
Closed Access | Times Cited: 1
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer
Maud de Dieuleveult, Claire Marchal, Anne Jouinot, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1106-1106
Open Access | Times Cited: 13
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells
Marzia Di Donato, Pia Giovannelli, Maria Vittoria Barone, et al.
Cells (2021) Vol. 11, Iss. 1, pp. 14-14
Open Access | Times Cited: 12
Preliminary study on miRNA in prostate cancer
Saimaitikari Abudoubari, Ke Bu, Yujie Mei, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Cohesive cancer invasion of the biophysical barrier of smooth muscle
William L. Harryman, Kendra D. Marr, Daniel Hernandez-Cortes, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 1, pp. 205-219
Open Access | Times Cited: 11
The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
Tao Xie, Xian‐Lu Song, Chong Wang, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1293-1301
Open Access | Times Cited: 11
MEDICINAL BIOMAGNETISMO IN THE TREATMENT OF PROSTATE CANCER
Angela Mara Rambo Martini, Luciane Neris Cazella, Yuri Martini, et al.
Health and Society (2023) Vol. 3, Iss. 01, pp. 438-464
Open Access | Times Cited: 3
Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality
Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 346-355
Open Access | Times Cited: 3
Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
Ye-Mao Liu, Anding Wu, Yun Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 3
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program
Faith Morley, Hari S. Iyer, Rulla M. Tamimi, et al.
Cancer Causes & Control (2023) Vol. 35, Iss. 3, pp. 509-521
Open Access | Times Cited: 2
HSPB8 facilitates prostate cancer progression via activating the JAK/STAT3 signaling pathway
Kan Zhang, Weiqi Yin, Luping Ma, et al.
Biochemistry and Cell Biology (2022) Vol. 101, Iss. 1, pp. 1-11
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top